Mingxi Lin

2.3k citations
24 papers · 1.5k · 1 hit paper · h-index 7

Impact in

Papers in

    • HER2/EGFR in Cancer Research 4
    • Cancer Immunotherapy and Biomarkers 2
    • Breast Cancer Treatment Studies 3
    • NF-κB Signaling Pathways 2

Mingxi Lin

23 papers receiving 1.4k citations

Mingxi Lin's Hit Papers

NF-κB in biology and targeted therapy: new insights and translational implications 2024 · 1.3k citations
1.3k0+1Years since publication4008001.2k

Peers

Mingxi Lin
Comparison fields: 5 of 96
  • Cancer Research 144
  • Complementary and alternative medicine 82
  • Immunology 153
  • Neurology 59
  • Oncology 127
Replace Yizi Jin with:
Yizi Jin China
Cheng Zeng China
Teng Zhou China
Junli Liu China
Ying Xing China
Liangbin Lin China
Ying He China
Chunfen Mo China
Konstantin Tsoyi United States
Marion Mußbacher Austria
Mingxi Lin relative to Yizi Jin China Yizi Jin's profile →
Citations per field
00.5×2×3×4×5×
Yizi Jin · 1×
Citations per year

Countries citing papers authored by Mingxi Lin

Since Specialization
Citations

This map shows the geographic impact of Mingxi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxi Lin more than expected).

Fields of papers citing papers by Mingxi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxi Lin. The network helps show where Mingxi Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Mingxi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mingxi Lin Line = papers co-authored together Mingxi Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
NF-κB in biology and targeted therapy: new insights and translational implications
Hit paper breakdown →
20241305
2 202035
3 202421
4 202320
5 202019
6 201614
7 20209
8 20207
9 20217
10 20256
11 20256
12 20215
13 20214
14 20224
15 20244
16 20222
17 20252
18 19891
19
Discussion on diabetes mellitus based on ‘spirit, physique, appetite, sleeping, urine and stool'
20141
20 20211

About Mingxi Lin

Mingxi Lin is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Infectious Diseases and Genetics, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Brain Metastases and Treatment (3 papers), Breast Cancer Treatment Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), NF-κB Signaling Pathways (2 papers), Advanced Breast Cancer Therapies (2 papers) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Cancer Research (144 citations), Complementary and alternative medicine (82 citations), Immunology (153 citations), Neurology (59 citations) and Oncology (127 citations). Mingxi Lin has collaborated with scholars based in China, Taiwan and Spain. Frequent co-authors include Yizi Jin, Cheng Zeng, Jian Zhang, Teng Zhou, Xinyu Chen, Xin Shen, Xiaomin Ye, Qing Guo, Xichun Hu and Xichun Hu. Their work appears in journals such as Cancer Medicine, Breast Cancer Targets and Therapy, EClinicalMedicine, Life Sciences and International Journal of Legal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact